The PEXIVAS Trial Team are always here to help. For further information about the PEXIVAS trial please contact us:
General enquiries:
For queries about collection of data and data analysis please contact the Birmingham Clinical Trials Unit (BCTU):
Postal address:
PEXIVAS Trial Office
Birmingham Clinical Trials Unit
Robert Aitken Institute
College of Medical and Dental Sciences
University of Birmingham
Edgbaston
Birmingham B15 2TT
Freepost address:
PEXIVAS Trials Office
FREEPOST RRKR-JUZR-HZHG
Birmingham Clinical Trials Unit
Robert Aitken Institute
College of Medical and Dental Sciences
University of Birmingham
Birmingham B15 2TT
Fax: +44 (0)121 415 9135
Email: PEXIVAS-trial@contacts.bham.ac.uk
PEXIVAS trial staff:
|
Elizabeth Brettell
|
Trials Manager
|
+44 (0)121 4159130
|
|
Noreen Akhtar
|
Trial Administrator
|
+44 (0)121 4159131
|
|
Emma Barsoum
|
Trial Administrator
|
+44 (0)121 4159133
|
|
Gemma Ryan
|
Data Manager
|
+44 (0)121 4159134
|
|
Charmaine Meek
|
Data Manager
|
+44 (0)121 4159132
|
|
Terry Hughes
|
Data Manager
|
+44 (0)121 415 9131
|
PEXIVAS Chief Investigators:
Dr David Jayne (Cambridge University Hospitals NHS Foundation Trust, United Kingdom)
Dr Peter A. Merkel (Boston University Medical School, Boston, USA)
Dr Michael Walsh (McMaster University Heath Science Centre, Hamilton, Canada)
Worldwide PEXIVAS study offices:
EUROPE
Dr David Jayne, Dr Alina Casian and Biljana Brezina, Vasculitis Research Office, Box 57 / Box 246, Addenbrooke’s Hospital, Hills Road, Cambridge, CB2 0QQ, United Kingdom, Tel: 01223 217259, Fax: 01223 586796.
USA
Dr Peter Merkel and Carol A. McAlear, Vasculitis Center, E5, Boston University School of Medicine, 72 East Concord Street E533, Boston, MA, 02118, USA, Tel: +01 617 414 2501, Fax: +01 617 414 2510.
CANADA
Dr. Michael Walsh, Department of Clinical Epidemiology and Biostatistics, Room 2C9, 1200 West Street Main, McMaster University Health Science Centre, Hamilton, Ontario, L8N 3Z5, Canada, Tel: +1 905 525 9140 ext 22876, Fax: +1 905 524 3841.
AUSTRALIA
Chen Au Peh and Carmel Hawley, University of Queensland, Level 1, Building 33, Princess Alexandra Hospital, Ipswich Rd, Wooloongabba, QLD 4102, Australia, Phone: +61 732402625.
Find out more information about our other renal trials and the University of Birmingham Clinical Trials Unit below:
BCTU
The University of Birmingham Clinical Trials Unit (BCTU) is a Research Unit within the School of Medicine specialising in the design, conduct and analysis of clinical trials.
GloMY
GloMY is a UK, multi centre, randomised controlled open label pilot trial of Myfortic plus short course steroids vs high-dose prolonged course steroid in patients with proteinuric FSGC and or no additional IgA nephropathy.
PREDNOS
PREDNOS is a national multi centre randomised double blind trial of long-term tapering versus standard prednisolone (steroid) therapy for the treatment of the initial episode of childhood nephrotic syndrome
PREDNOS 2
Short course daily prednisolone therapy at the time of upper respiratory tract infection in children with relapsing steroid sensitive nephrotic syndrome; the PREDNOS 2 study.